pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
718
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
PA-001
Coronavirus Disease 2019 (COVID-19)
PeptiAID Inc
0
catalysts
Phase 3
PAX-101
suramin hexasodium
African Trypanosomiasis
Fibroblast growth factor 1
Kuvatris Therapeutics Inc
0
catalysts
Phase 2
PBGENE-HBV
Hepatitis B
$DTIL
PRECISION BIOSCIENCES INC
0
catalysts
← prev
page 11 of 24
next →
131
Pain
89
Neurology
1
Phase 3
PF-06760805
Streptococcal Infections
$PFE
PFIZER INC
0
catalysts
Preclinical
PIND-140908
Macro Biologics Inc
0
catalysts
Phase 2
PL-18
Bacterial Vaginosis
Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
0
catalysts
Preclinical
PRF-130 ER
Osteomyelitis
$PRFX
PRF Technologies Ltd.
0
catalysts
Phase 1
PSP-001
Norovirus Infections
Prosit Sole Biotechnology (Beijing) Co Ltd
0
catalysts
Preclinical
Pan-Coronavirus
Coronavirus Disease 2019 (COVID-19)
$DCOY
Decoy Therapeutics Inc.
0
catalysts
Marketed
Paser
Paser (para aminosalicylic acid [INN])
Tuberculosis
Eurocept Pharmaceuticals
0
catalysts
Preclinical
ProLectin-A
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
$BIXT
BIOXYTRAN, INC
0
catalysts
Phase 2
ProLectin-M
Coronavirus Disease 2019 (COVID-19)
$BIXT
BIOXYTRAN, INC
0
catalysts
Phase 2
QTP-101
Tuberculosis
Quratis Inc
0
catalysts
Phase 2
R-327
Urinary Tract Infections
Recce Pharmaceuticals Ltd
0
catalysts
Phase 2
RAGE Inhibitor
Coronavirus Disease 2019 (COVID-19)
Galactica Pharmaceuticals Inc
0
catalysts
Phase 1
RBM-001
Coronavirus Disease 2019 (COVID-19)
Rock Biomedical Inc
0
catalysts
Preclinical
RECCE-529
Coronavirus Disease 2019 (COVID-19)
Recce Pharmaceuticals Ltd
0
catalysts
Phase 1
RIM-730
Coronavirus Disease 2019 (COVID-19)
RNAimmune Inc
0
catalysts
Phase 2
RIV3 + rC19
Coronavirus Disease 2019 (COVID-19)
$SNY
Sanofi
0
catalysts
Phase 1
RQ-01
Coronavirus Disease 2019 (COVID-19)
Red Queen Therapeutics Inc
0
catalysts
Preclinical
RSBT-001
Coronavirus Disease 2019 (COVID-19)
RS BioTherapeutics Inc
0
catalysts
Phase 2
RSLV-132
Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)
Resolve Therapeutics LLC
0
catalysts
Preclinical
RSV DT-preF
Respiratory Syncytial Virus (RSV) Infections
Calder Biosciences Inc
0
catalysts
Preclinical
RT-002
Sarcopenia
Ridgeline Therapeutics LLC
0
catalysts
Phase 1
RV-1770
Respiratory Syncytial Virus (RSV) Infections
Hualan Biological Vaccine Inc
0
catalysts
Preclinical
Recombinant Protein to Activate p38 MAP Kinase for Round Worm Infections
Nematodal (Round Worm) Infections
University of California San Diego
0
catalysts
Phase 2
S-337395
Respiratory Syncytial Virus (RSV) Infections
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Phase 2
S-4V2
Bacillary Dysentery (Shigellosis)
$VALN
Valneva SE
0
catalysts
Phase 1
SAV-001
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Sumagen Canada Inc
0
catalysts
Preclinical
SB-2
Coronavirus Disease 2019 (COVID-19)
SunBio Inc
0
catalysts
